146 related articles for article (PubMed ID: 16858677)
21. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Zhou J; Wang S; Lu J; Li J; Ding Y
Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
[TBL] [Abstract][Full Text] [Related]
22. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.
Zeng Z; Zhou Y; Xiong W; Luo X; Zhang W; Li X; Fan S; Cao L; Tang K; Wu M; Li G
J Cancer Res Clin Oncol; 2007 Feb; 133(2):71-81. PubMed ID: 16941191
[TBL] [Abstract][Full Text] [Related]
23. IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression.
Kuo YS; Tang YB; Lu TY; Wu HC; Lin CT
J Pathol; 2010 Nov; 222(3):299-309. PubMed ID: 20635349
[TBL] [Abstract][Full Text] [Related]
24. Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells.
Lee JW; Hsiao WT; Chen HY; Hsu LP; Chen PR; Lin MD; Chiu SJ; Shih WL; Hsu YC
Int J Cancer; 2010 Mar; 126(6):1353-66. PubMed ID: 19739116
[TBL] [Abstract][Full Text] [Related]
25. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
Yang H; Zhao R; Lee MH
Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
[TBL] [Abstract][Full Text] [Related]
26. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
27. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
Chua HH; Yeh TH; Wang YP; Sheen TS; Shew JY; Huang YT; Tsai CH
Head Neck; 2008 Dec; 30(12):1575-85. PubMed ID: 18798303
[TBL] [Abstract][Full Text] [Related]
28. An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.
Chai SJ; Ahmad Zabidi MM; Gan SP; Rajadurai P; Lim PVH; Ng CC; Yap LF; Teo SH; Lim KP; Patel V; Cheong SC
Dis Markers; 2019; 2019():3857853. PubMed ID: 31236144
[TBL] [Abstract][Full Text] [Related]
29. [Differentially expressed genes between upward and downward progressing types of nasopharyngeal carcinoma].
Liang WJ; Qiu F; Hong MH; Guo L; Qin HD; Liu QC; Zhang XS; Mai HQ; Xiang YQ; Min HQ; Zeng YX
Ai Zheng; 2008 May; 27(5):460-5. PubMed ID: 18479593
[TBL] [Abstract][Full Text] [Related]
30. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines.
Ai MD; Li LL; Zhao XR; Wu Y; Gong JP; Cao Y
Cell Res; 2005 Oct; 15(10):777-84. PubMed ID: 16246267
[TBL] [Abstract][Full Text] [Related]
31. [Differentially expressed transcription factor-related genes in nasopharyngeal carcinoma and nasopharyngeal tissues].
Wang S; Lu LC; Fang WY; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):146-9. PubMed ID: 17355921
[TBL] [Abstract][Full Text] [Related]
32. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx.
Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY
Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751
[TBL] [Abstract][Full Text] [Related]
33. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient.
Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
Clin Cancer Res; 2003 Mar; 9(3):1033-8. PubMed ID: 12631603
[TBL] [Abstract][Full Text] [Related]
34. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
[TBL] [Abstract][Full Text] [Related]
35. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Xie L; Xu L; He Z; Zhou W; Wang L; Zhang L; Lan K; Ren C; Liu W; Yao K
J Cancer Res Clin Oncol; 2000 Jul; 126(7):400-6. PubMed ID: 10929762
[TBL] [Abstract][Full Text] [Related]
36. [Differential gene expression profiling for identification of protective transcription factors in different subtypes of nasopharyngeal carcinoma].
Huang C; Lin P; Wang J; Huang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1565-70. PubMed ID: 24273254
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways.
Fu WM; Lu YF; Hu BG; Liang WC; Zhu X; Yang HD; Li G; Zhang JF
Oncotarget; 2016 Jan; 7(4):4712-23. PubMed ID: 26717040
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of splicing variants in NASG 3'UTR, down-regulated in nasopharyngeal carcinoma, and its expression in multiple cancer tissues].
Zhang BC; Zhu SG; Xiang JJ; Zhou M; Nie XM; Xiao BY; Li XL; Li GY
Ai Zheng; 2003 May; 22(5):477-80. PubMed ID: 12753706
[TBL] [Abstract][Full Text] [Related]
40. [Gene expression profile of immune cells from patients with nasopharyngeal carcinoma of stage T3-4N0].
Xiao XB; Mai HQ; Cao SM; Zhang Y; Sun R; Hong MH
Ai Zheng; 2005 Feb; 24(2):135-40. PubMed ID: 15694020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
